Quantum Biopharma-B Sub VotQNTM
13F holders, Q4 2024 (December 31)9holders −3
0new positions
4sold out
$3.67avg. 13F price*
At the end of Q4 2024, 9 institutions reported holding Quantum Biopharma-B Sub Vot (QNTM) in their 13F filings, down 3 from Q3 2024. 0 opened new positions and 4 sold out. The largest holders were AdvisorShares Investments LLC ($254K), Royal Bank of Canada ($1K) and Group One Trading LLC ($489).
- Company
- Quantum Biopharma-B Sub Vot
- CUSIP
- 74764Y205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 4 | $86K |
All 13F filers, Q3 2024 → Q4 2024: 43,131 shares bought and 21,525 shares sold, net +21,606 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| AdvisorShares Investments LLC | 0.05% | Add +163.3% | 69,078 | $254K |
| Royal Bank of Canada | 0.00% | Add +254.2% | 379 | $1K |
| Group One Trading LLC | 0.00% | Reduce -22.7% | 133 | $489 |
| SBI Securities Co., Ltd. | 0.00% | — | 100 | $368 |
| National Bank of Canada | 0.00% | Reduce -29.2% | 34 | $123 |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +100.0% | 28 | $101 |
| Osaic Holdings, Inc. | 0.00% | No change | 15 | $55 |
| Avior Wealth Management, LLC | 0.00% | No change | 3 | $11 |
| TD Waterhouse Canada Inc. | 0.00% | Reduce -33.3% | 2 | $7 |
"% of holder's portfolio" is QNTM's weight in each manager's 13F, not the share of Quantum Biopharma-B Sub Vot the manager owns.